Amphipathic peptides can act as an anticoagulant by competing with phospholipid membranes for blood coagulation factors.
暂无分享,去创建一个
[1] W. Ageno. Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials , 2009, Expert review of cardiovascular therapy.
[2] H. Bounameaux. The novel anticoagulants: entering a new era. , 2009, Swiss medical weekly.
[3] Christopher R. Emerson,et al. Rivaroxaban: A Novel, Oral, Direct Factor Xa Inhibitor , 2009, Pharmacotherapy.
[4] J. Ansell,et al. Apixaban, an oral direct Factor Xa inhibitor: awaiting the verdict , 2008 .
[5] S. Spinler,et al. Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for Prophylaxis and Treatment of Thromboembolic Diseases , 2008, Pharmacotherapy.
[6] Henry T. Peng,et al. Characterization of an ideal amphipathic peptide as a procoagulant agent. , 2008, The Biochemical journal.
[7] J. Hirsh,et al. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.
[8] P. Shek,et al. The Use of Ideal Amphipathic Helical Peptides To Reduce Hemorrhage In Vivo. , 2007 .
[9] E. Frenkel,et al. Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use. , 2005, Hematology/oncology clinics of North America.
[10] G. E. Gilbert,et al. Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites. , 2003, Blood.
[11] B. Furie,et al. The Gla Domain of Human Prothrombin Has a Binding Site for Factor Va* , 2000, The Journal of Biological Chemistry.
[12] M. Blostein,et al. Amphipathic helices support function of blood coagulation factor IXa. , 2000, Biochemistry.
[13] B. Furie,et al. Vitamin K-Dependent Biosynthesis of γ-Carboxyglutamic Acid , 1999 .
[14] J. Dufourcq,et al. The amphipathic helix concept: length effects on ideally amphipathic LiKj(i=2j) peptides to acquire optimal hemolytic activity. , 1999, Biochimica et biophysica acta.
[15] K. Croce,et al. Interaction between soluble P-selectin and soluble P-selectin glycoprotein ligand 1: equilibrium binding analysis. , 1998, Biochemistry.
[16] K. Ohashi,et al. Cell Adhesion to Phosphatidylserine Mediated by a Product of Growth Arrest-specific Gene 6* , 1997, The Journal of Biological Chemistry.
[17] J. Rand,et al. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism. , 1997, The New England journal of medicine.
[18] Margaret Jacobs,et al. Identification of the Phospholipid Binding Site in the Vitamin K-dependent Blood Coagulation Protein Factor IX* , 1996, The Journal of Biological Chemistry.
[19] B. Seaton,et al. Ca2+-bridging mechanism and phospholipid head group recognition in the membrane-binding protein annexin V , 1995, Nature Structural Biology.
[20] J. Dufourcq,et al. The amphipathic α‐helix concept , 1994 .
[21] B. Furie,et al. Molecular and cellular biology of blood coagulation. , 1992, The New England journal of medicine.
[22] J. Hirsh. Oral anticoagulant drugs. , 1991, The New England journal of medicine.
[23] Kenneth G. Mann,et al. Surface-dependent reactions of the vitamin K-dependent enzyme complexes , 1990 .
[24] J. Bloom. The interactions of factors X and IX with phospholipid. , 1989, Thrombosis research.
[25] J. Rosing,et al. Calcium-independent activation of prothrombin on membranes with positively charged lipids. , 1988, Biochemistry.
[26] C. Esmon,et al. The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. , 1987, The Journal of biological chemistry.
[27] P. Comfurius,et al. Changes in membrane phospholipid distribution during platelet activation. , 1983, Biochimica et biophysica acta.
[28] A. Bangham,et al. A Correlation between Surface Charge and Coagulant Action of Phospholipids , 1961, Nature.
[29] Y. Seki. [Unfractionated heparin]. , 2011, Rinsho byori. The Japanese journal of clinical pathology.
[30] P. D. de Groot,et al. Tests for lupus anticoagulant revisited. , 2004, Thrombosis research.
[31] G. Huang,et al. Structural basis of membrane binding by Gla domains of vitamin K–dependent proteins , 2003, Nature Structural Biology.
[32] B. Furie,et al. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. , 1999, Blood.
[33] J. Dufourcq,et al. The amphipathic alpha-helix concept. Application to the de novo design of ideally amphipathic Leu, Lys peptides with hemolytic activity higher than that of melittin. , 1994, FEBS letters.
[34] K. Mann,et al. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. , 1990, Blood.